Glaxosmithkline | GSK - Le Revenu D'Intérêts





Le Revenu D'Intérêts Changement Date
AbbVie USD 59M 13M 2025-12
AstraZeneca USD 73M 62M 2026-03
Aurora Cannabis CAD 1.85M 120K 2025-09
Bausch Health Companies USD 9M 6M 2025-12
Corcept Therapeutics USD 5.42M 399K 2025-12
Drreddys Laboratories INR 796M 332M 2025-12
Eli Lilly USD 65M 25M 2025-09
GlaxoSmithKline GBP 22M 96M 2026-03
Glaxosmithkline GBP 26M 24M 2025-09
J&J USD 2.14 237M 2026-03
Merck USD 69M 27M 2025-12
Pacira USD 2.3M 6.24M 2025-12
Pfizer USD 115M 51M 2026-03
Phibro Animal Health USD 0.08 0.09 2024-12
Sanofi EUR 33M 81M 2025-12
Supernus Pharmaceuticals USD 2.02M 254K 2025-12
Takeda JPY 87.87B 43.48B 2025-12
Zoetis USD 25M 1000K 2025-12